Additionally, elevated GRB7 expression was related to poorer Disease-free survival (DFS) in patients with CHOL, COAD, LGG, and PRAD (Figures 6F, 6G, 6I, 6J). Meanwhile, higher GRB7 expression was associated with improved DFS in patients with ACC and KIRC (p<0.05) (Figure 6E). This evidence concerns the gene GRB7 and adrenal cortex carcinoma.